Trial Profile
A Two-Week, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain in Healthy Male Volunteers.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Feb 2010
Price :
$35
*
At a glance
- Drugs Mifepristone (Primary) ; Olanzapine
- Indications Weight gain
- Focus Therapeutic Use
- Sponsors Corcept Therapeutics
- 11 Oct 2008 New trial record.